Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Davies

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Lancet. Haematology|December 22, 2015
First-line therapy for CML: decisions, decisionsJeff Davies
The Lancet. Oncology|August 23, 2011
First-line therapy for CML: nilotinib comes of ageJeff Davies
International Journal of Audiology|November 26, 2016
Pre-market version of a commercially available hearing instrument with a tinnitus sound generator: feasibility of evaluation in a clinical trialMagdalena Sereda, Jeff Davies, Deborah A Hall
Ground Water|April 12, 2005
Transmissivity variations in mudstonesAlan M MacDonald, Simon J Kemp, Jeff Davies
Frontiers in Aging Neuroscience|October 7, 2016
Neuroanatomical Alterations in Tinnitus Assessed with Magnetic Resonance ImagingThomas W Allan, Julien Besle, Dave R M Langers, et al.
British Journal of Haematology|March 13, 2021
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experienceAmanda Jurgensen-Rauch, Suzanne Gibbs, Maresa Farrell, et al.
Blood|September 9, 2020
Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHDJennifer A Ball, Andrew Clear, James Aries, et al.
BMJ Open|January 29, 2025
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)Ronjon Chakraverty, Emma Kempshall, Fiona Dignan, et al.
European Urology|October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Lancet. Haematology|December 22, 2015
First-line therapy for CML: decisions, decisionsJeff Davies
The Lancet. Oncology|August 23, 2011
First-line therapy for CML: nilotinib comes of ageJeff Davies
International Journal of Audiology|November 26, 2016
Pre-market version of a commercially available hearing instrument with a tinnitus sound generator: feasibility of evaluation in a clinical trialMagdalena Sereda, Jeff Davies, Deborah A Hall
Ground Water|April 12, 2005
Transmissivity variations in mudstonesAlan M MacDonald, Simon J Kemp, Jeff Davies
Frontiers in Aging Neuroscience|October 7, 2016
Neuroanatomical Alterations in Tinnitus Assessed with Magnetic Resonance ImagingThomas W Allan, Julien Besle, Dave R M Langers, et al.
British Journal of Haematology|March 13, 2021
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experienceAmanda Jurgensen-Rauch, Suzanne Gibbs, Maresa Farrell, et al.
Blood|September 9, 2020
Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHDJennifer A Ball, Andrew Clear, James Aries, et al.
BMJ Open|January 29, 2025
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)Ronjon Chakraverty, Emma Kempshall, Fiona Dignan, et al.
European Urology|October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
Pageof 1